Abcam Parkinson’s Disease
Parkinson’s is a neurodegenerative condition in which regions of the brain become increasingly more damaged over time. The physical symptoms of Parkinson’s are commonly tremor and reduced movement, but patients can also suffer from depression, balance issues, and problems with sleeping and memory. The disease affects around 6 million people worldwide and, as of yet, there is no known cure.
Abcam want to help the Parkinson’s community to overcome those hurdles.
Robust research requires equally robust tools. In the case of understanding disease pathways, such as those in Parkinson’s, this often means antibodies that reliably bind key targets. Unfortunately, many existing antibodies lack sufficient quality control data, are challenging to obtain, or are tied up in convoluted license agreements, restricting their use.
To bring the tools needed for Parkinson’s disease research, Abcam partnered with The Michael J. Fox Foundation (MJFF) to develop rabbit monoclonal antibodies against promising targets.
To find out more about Abcam’s work on Parkinson’s Disease please go to: https://www.abcam.com/neuroscience/parkinsons-disease#what
Cambridge Video Production